Clinical trial
A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia
NCT04255680 is registered in ClinicalTrials.gov with Larimar Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia
- Lead sponsor
- Larimar Therapeutics, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 14, 2020
- Completion date
- June 30, 2020
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.